American Vietnamese Biotech (HSTC:AMV) Debt-to-Asset : 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is American Vietnamese Biotech Debt-to-Asset?

American Vietnamese Biotech HSTC:AMV -8.33% Debt-to-Asset is 0.00 as of . 20.

American Vietnamese Biotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was ₫0.00 Mil.

American Vietnamese Biotech  (HSTC:AMV) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

American Vietnamese Biotech Debt-to-Asset Related Terms

American Vietnamese Biotech Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for American Vietnamese Biotech's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech Debt-to-Asset Chart

American Vietnamese Biotech Annual Data
Trend
Debt-to-Asset

American Vietnamese Biotech Quarterly Data
Debt-to-Asset

HSTC:AMV vs HSTC, STLT, CTBO: Debt-to-Asset Comparison

For the Biotechnology subindustry, American Vietnamese Biotech's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Vietnamese Biotech Debt-to-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's Debt-to-Asset falls into.


American Vietnamese Biotech Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

American Vietnamese Biotech's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

American Vietnamese Biotech's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.00 mean?
American Vietnamese Biotech (HSTC:AMV) has a Debt-to-Asset of 0.00 as of . 20. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on American Vietnamese Biotech and its competitors.
Is American Vietnamese Biotech's Debt-to-Asset too high?
American Vietnamese Biotech's current Debt-to-Asset is 0.00.
How does American Vietnamese Biotech's Debt-to-Asset compare to HSTC and STLT?
American Vietnamese Biotech's Debt-to-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Biotechnology company?
A good Debt-to-Asset depends on the Biotechnology industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on American Vietnamese Biotech and its competitors. American Vietnamese Biotech's current Debt-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Vietnamese Biotech stock overvalued right now?
American Vietnamese Biotech (HSTC:AMV) has a current Debt-to-Asset of 0.00. The current Debt-to-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For American Vietnamese Biotech (HSTC:AMV), the current Debt-to-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Vietnamese Biotech Business Description

Address No. 85 Hoang Van Thai, 4th Floor, Phu Ma Duong Building, Tan Phu Ward, District 7, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments, and chemicals; producing and trading vaccines and medical biological products.